For
the past fifty-five years, physicians have relied upon a relatively
inaccurate tissue test, the Pap smear, to diagnose cervical cancer: at least 25% of women with pre-stage or advanced cervical
cancer are not being identified during routine gynecological examination
(Pap smear)*.
The Pap smear has accuracy
close to 70%; whereas the CSATM
test is close to 100%.
Not
only the CSATM test is highly superior to the Pap smear or HPV
testing** in terms of its
accuracy but also, as a convenient blood test, it will be more acceptable
to women who are unwilling to undergo a pelvic
exam or whose cultural taboos prevent them from undergoing sample collection.
The CSATM
overcomes deficiencies of the Pap smear by being a convenient blood test
and highly accurate.
* cf. S.L. Parker,
T. Tong and S. Bolden, Cancer Statistics 1997, CA Cancer J. Clin. 47 (1997), 1-27
**Only about 1 to 5% of the
HPV (Human Papilloma Virus) positive women will develop cervical cancer.
